For: | Da CL, Xin Y, Zhao J, Luo XD. Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions. World J Gastroenterol 2009; 15(32): 4055-4061 [PMID: 19705503 DOI: 10.3748/wjg.15.4055] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i32/4055.htm |
Number | Citing Articles |
1 |
Wei Kang, Alfred SL Cheng, Jun Yu, Ka Fai To. Emerging role of Hippo pathway in gastric and other gastrointestinal cancers. World Journal of Gastroenterology 2016; 22(3): 1279-1288 doi: 10.3748/wjg.v22.i3.1279
|
2 |
Guo-wen Ding, Xu-yu Gu, Zhe Dai, Hui-wen Pan, Xiao-yan Wang, Heng Zhang, Yu Fan. Association of Genetic Polymorphisms in FOXA1 with the Progression of Genetic Susceptibility to Gastric Cancer. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/3075837
|
3 |
Yiting Qiao, Tongyu Li, Shusen Zheng, Hangxiang Wang. The Hippo pathway as a drug target in gastric cancer. Cancer Letters 2018; 420: 14 doi: 10.1016/j.canlet.2018.01.062
|
4 |
Xiaobin Hu, Yan Xin, Yuping Xiao, Jing Zhao. Overexpression of YAP1 is Correlated with Progression, Metastasis and Poor Prognosis in Patients with Gastric Carcinoma. Pathology & Oncology Research 2014; 20(4): 805 doi: 10.1007/s12253-014-9757-y
|
5 |
Hui-Xia Zheng, Li-Na Wu, Hong Xiao, Qian Du, Jian-Fang Liang. Inhibitory effects of dobutamine on human gastric adenocarcinoma. World Journal of Gastroenterology 2014; 20(45): 17092-17099 doi: 10.3748/wjg.v20.i45.17092
|
6 |
J. Zhang, Z-P. Xu, Y-C. Yang, J-S. Zhu, Z. Zhou, W-X. Chen. Expression and Yes-Associated Protein in Gastric Adenocarcinoma and Inhibitory Effects of its Knockdown on Gastric Cancer Cell Proliferation and Metastasis. International Journal of Immunopathology and Pharmacology 2012; 25(3): 583 doi: 10.1177/039463201202500304
|
7 |
Cristiana Branco da Cunha, Darinka D. Klumpers, Sandeep T. Koshy, James C. Weaver, Ovijit Chaudhuri, Raquel Seruca, Fátima Carneiro, Pedro L. Granja, David J. Mooney. CD44 alternative splicing in gastric cancer cells is regulated by culture dimensionality and matrix stiffness. Biomaterials 2016; 98: 152 doi: 10.1016/j.biomaterials.2016.04.016
|
8 |
J. Zhang, Y-C. Yang, J-S. Zhu, Z. Zhou, W-X. Chen. Clinicopathologic Characteristics and Yes-Associated Protein 1 Overexpression and its Relationship to Tumor Biomarkers in Gastric Cancer. International Journal of Immunopathology and Pharmacology 2012; 25(4): 977 doi: 10.1177/039463201202500415
|
9 |
Francesca Zanconato, Michelangelo Cordenonsi, Stefano Piccolo. YAP/TAZ at the Roots of Cancer. Cancer Cell 2016; 29(6): 783 doi: 10.1016/j.ccell.2016.05.005
|
10 |
Jia-Rong Meng, Hui-Zhong Tang, Kai-Zong Zhou, Wu-Hong Shen, He-Yi Guo. TFF3 and survivin expressions associate with a lower survival rate in gastric cancer. Clinical and Experimental Medicine 2013; 13(4): 297 doi: 10.1007/s10238-012-0210-9
|
11 |
Jiaxin Yong, Yuan Li, Sihan Lin, Zhenning Wang, Yan Xu. Inhibitors Targeting YAP in Gastric Cancer: Current Status and Future Perspectives. Drug Design, Development and Therapy 2021; : 2445 doi: 10.2147/DDDT.S308377
|
12 |
Suman Mohajan, Praveen Kumar Jaiswal, Mousa Vatanmakarian, Hassan Yousefi, Saikolappan Sankaralingam, Suresh K. Alahari, Sweaty Koul, Hari K. Koul. Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer. Cancer Letters 2021; 507: 112 doi: 10.1016/j.canlet.2021.03.006
|
13 |
Shangfu Li, Qiuli Liu, Depeng Wu, Tianwei He, Jinbo Yuan, Heng Qiu, Jennifer Tickner, Song Guo Zheng, Xiaojuan Li, Jiake Xu, Limin Rong. PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling. Cell Death & Disease 2020; 11(9) doi: 10.1038/s41419-020-02947-3
|
14 |
Beatrice Messina, Federica Lo Sardo, Stefano Scalera, Lorenzo Memeo, Cristina Colarossi, Marzia Mare, Giovanni Blandino, Gennaro Ciliberto, Marcello Maugeri-Saccà, Giulia Bon. Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression. Cell Death & Disease 2023; 14(1) doi: 10.1038/s41419-023-05568-8
|
15 |
Rui Yan, JianJian Li, Ying Zhou, Li Yao, Ruya Sun, Ying Xu, Yang Ge, Guangyu An. Inhibition of DCLK1 down-regulates PD-L1 expression through Hippo pathway in human pancreatic cancer. Life Sciences 2020; 241: 117150 doi: 10.1016/j.lfs.2019.117150
|
16 |
Lin Zhu, Juan Lu, Zhijun Bao, Shiwen Guo, Weiguo Li. Mechanism of Baclofen Inhibiting the Proliferation and Metastasis of GBM by Regulating YAP. Journal of Chemistry 2021; 2021: 1 doi: 10.1155/2021/2753571
|
17 |
Masayuki Tsuneki, Joseph A. Madri. Adhesion Molecule-Mediated Hippo Pathway Modulates Hemangioendothelioma Cell Behavior. Molecular and Cellular Biology 2014; 34(24): 4485 doi: 10.1128/MCB.00671-14
|
18 |
Xia Qian, Wei Zhang, Hua Yang, Lanjing Zhang, Ningling Kang, Jinping Lai. Role of Yes-associated Protein-1 in Gastrointestinal Cancers and Hepatocellular Carcinoma. Exploratory Research and Hypothesis in Medicine 2021; 0(000): 000 doi: 10.14218/ERHM.2021.00017
|
19 |
Duyen Amy Bui, Wendy Lee, Anne E. White, J. Wade Harper, Ron C. J. Schackmann, Michael Overholtzer, Laura M. Selfors, Joan S. Brugge. Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP. Science Signaling 2016; 9(417) doi: 10.1126/scisignal.aaa9227
|
20 |
Keun-Wook Lee, Sung Sook Lee, Jun-Eul Hwang, Hee-Jin Jang, Hyun-Sung Lee, Sang Cheul Oh, Sang Ho Lee, Bo Hwa Sohn, Sang Bae Kim, Jae-Jun Shim, Woojin Jeong, Minse Cha, Jae-Ho Cheong, Jae Yong Cho, Jae Yun Lim, Eun Sung Park, Sang Cheol Kim, Yoon-Koo Kang, Sung Hoon Noh, Jaffer A. Ajani, Ju-Seog Lee. Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer. Clinical Cancer Research 2016; 22(24): 6228 doi: 10.1158/1078-0432.CCR-15-2468
|
21 |
Shu‐Er Chow, Chia‐Chi Hsu, Cheng‐Ta Yang, Yaa‐Jyuhn J. Meir. YAP co‐localizes with the mitotic spindle and midbody to safeguard mitotic division in lung‐cancer cells. The FEBS Journal 2023; 290(24): 5704 doi: 10.1111/febs.16926
|
22 |
Shangfu Li, Tianwei He, Depeng Wu, Liangming Zhang, Ruiqiang Chen, Bin Liu, Jinbo Yuan, Jennifer Tickner, An Qin, Jiake Xu, Limin Rong. Conditional Knockout of PKC-δ in Osteoclasts Favors Bone Mass Accrual in Males Due to Decreased Osteoclast Function. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00450
|
23 |
Zhenqiang Sun, Ruiwei Xu, Xiayu Li, Weiguo Ren, Chunlin Ou, Qisan Wang, Han Zhang, Xuemei Zhang, Jian Ma, Haijiang Wang, Guiyuan Li, Yves St-Pierre. Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis. PLOS ONE 2015; 10(8): e0135119 doi: 10.1371/journal.pone.0135119
|
24 |
JUNYAN ZHANG, ZHI ZHU, ZHE SUN, XUREN SUN, ZHENNING WANG, HUIMIAN XU. Survivin gene expression increases gastric cancer cell lymphatic metastasis by upregulating vascular endothelial growth factor-C expression levels. Molecular Medicine Reports 2014; 9(2): 600 doi: 10.3892/mmr.2013.1858
|
25 |
Chen Yang, Huaqiang Tao, Haifeng Zhang, Yu Xia, Jiaxiang Bai, Gaoran Ge, Wenming Li, Wei Zhang, Long Xiao, Yaozeng Xu, Zhirong Wang, Ye Gu, Huilin Yang, Yu Liu, Dechun Geng. TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss. Autophagy 2022; 18(12): 2817 doi: 10.1080/15548627.2022.2048432
|
26 |
Xin Wang, Guoli Huai, Hailian Wang, Yuande Liu, Ping Qi, Wei Shi, Jie Peng, Hongji Yang, Shaoping Deng, Yi Wang. Mutual regulation of the Hippo/Wnt/LPA/TGF‑β signaling pathways and their roles in glaucoma (Review). International Journal of Molecular Medicine 2017; doi: 10.3892/ijmm.2017.3352
|
27 |
Wei Kang, Joanna H.M. Tong, Anthony W.H. Chan, Tin-Lap Lee, Raymond W.M. Lung, Patrick P.S. Leung, Ken K.Y. So, Kaichun Wu, Daiming Fan, Jun Yu, Joseph J.Y. Sung, Ka-Fai To. Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis. Clinical Cancer Research 2011; 17(8): 2130 doi: 10.1158/1078-0432.CCR-10-2467
|
28 |
Wenjing Zhang, Yijun Gao, Fuming Li, Xinyuan Tong, Yan Ren, Xiangkun Han, Shun Yao, Fei Long, Zhongzhou Yang, Hengyu Fan, Lei Zhang, Hongbin Ji. YAP Promotes Malignant Progression of Lkb1-Deficient Lung Adenocarcinoma through Downstream Regulation of Survivin. Cancer Research 2015; 75(21): 4450 doi: 10.1158/0008-5472.CAN-14-3396
|
29 |
Yanyan Han. Analysis of the role of the Hippo pathway in cancer. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1869-4
|
30 |
Dong‐E Tang, Yong Dai, Lie‐Wen Lin, Yong Xu, Dong‐Zhou Liu, Xiao‐Ping Hong, Hao‐Wu Jiang, Song‐Hui Xu. RETRACTED: STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling. Cancer Science 2019; 110(10): 3145 doi: 10.1111/cas.14166
|
31 |
Katsuhiro Yoshimura, Gengyi Zou, Yibo Fan, Kohei Yamashita, Lingzhi Wang, Jingjing Wu, Ruiping Wang, Shan Shao, Ailing W. Scott, Jiankang Jin, Melissa Pool Pizzi, Xiaodan Yao, Calena-Abel Brown, Linghua Wang, Qiong Gan, Rebecca E. Waters, Feng Yin, Shumei Song, Shilpa S. Dhar, Jaffer A. Ajani. HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer. Cancer Letters 2025; 610: 217354 doi: 10.1016/j.canlet.2024.217354
|
32 |
Shi Jiao, Huizhen Wang, Zhubing Shi, Aimei Dong, Wenjing Zhang, Xiaomin Song, Feng He, Yicui Wang, Zhenzhen Zhang, Wenjia Wang, Xin Wang, Tong Guo, Peixue Li, Yun Zhao, Hongbin Ji, Lei Zhang, Zhaocai Zhou. A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer. Cancer Cell 2014; 25(2): 166 doi: 10.1016/j.ccr.2014.01.010
|
33 |
Amirreza Mahmoudzadeh-Sagheb, Mehran Panahi, Setareh Jami, Bita Moudi, Hamidreza Mahmoudzadeh-Sagheb, Zahra Heidari. Survivin as a potential biomarker for early diagnosis of the progression of precancerous lesions to gastric cancer. The International Journal of Biological Markers 2024; 39(1): 52 doi: 10.1177/03936155231217268
|
34 |
Laura Bongiovanni, Eliane J. Müller, Leonardo Della Salda. Survivin in skin pathologies. Experimental Dermatology 2011; 20(6): 457 doi: 10.1111/j.1600-0625.2011.01273.x
|
35 |
Xiaopeng Cai, Shuai Ma, Ming Gu, Cong Zu, Wenzhi Qu, Xinyu Zheng. Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer. Diagnostic Pathology 2012; 7(1) doi: 10.1186/1746-1596-7-52
|
36 |
Shanshan Huang, Lingling Zhu, Yuan Cao, Li Li, Yongtao Xie, Jun Deng, Jianping Xiong. Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients. Oncotarget 2017; 8(46): 80303 doi: 10.18632/oncotarget.17932
|
37 |
Luo Zhang, Xing Song, Xiaodong Li, Changping Wu, Jingting Jiang. Yes-Associated Protein 1 as a Novel Prognostic Biomarker for Gastrointestinal Cancer: A Meta-Analysis. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/4039173
|
38 |
Hasegawa Takashi, Sugihara Takaaki, Hoshino Yoshiki, Tarumoto Ryohei, Matsuki Yukako, Kanda Tsutomu, Takata Tomoaki, Nagahara Takakazu, Matono Tomomitsu, Isomoto Hajime. Photosensitizer verteporfin inhibits the growth of YAP‑ and TAZ‑dominant gastric cancer cells by suppressing the anti‑apoptotic protein Survivin in a light‑independent manner. Oncology Letters 2021; 22(4) doi: 10.3892/ol.2021.12964
|
39 |
Ying Tan, Qiu-Meng Li, Ning Huang, Si Cheng, Guan-Jian Zhao, Hong Chen, Song Chen, Zhao-Hua Tang, Wen-Qian Zhang, Qin Huang, Yuan Cheng. Upregulation of DACT2 suppresses proliferation and enhances apoptosis of glioma cell via inactivation of YAP signaling pathway. Cell Death & Disease 2017; 8(8): e2981 doi: 10.1038/cddis.2017.385
|
40 |
Luo Yuan Yuan, Wu Shuai, Zou Yuan-Peng, Jiang Ting, Xia Wei, He Yu-Qin, Hong Huang-ming. Relationship between Yes-Associated Protein 1 and Prognosis of Digestive System Neoplasm: Quantitative Analysis and Bioinformatics Analysis Based on 4023 Patients. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/3798694
|
41 |
Shangfu Li, Bin Liu, Liangming Zhang, Limin Rong. Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function. Bone 2014; 61: 164 doi: 10.1016/j.bone.2014.01.010
|
42 |
Hafsa Anees Qureshi, Ali Azimi, Jillian Wells, Pablo Fernandez‐Penas. Tape stripped stratum corneum samples are suitable for diagnosis and comprehensive proteomic investigation in mycosis fungoides. PROTEOMICS – Clinical Applications 2023; 17(3) doi: 10.1002/prca.202200039
|
43 |
Paulina Cerda-Opazo, Manuel Valenzuela-Valderrama, Ignacio Wichmann, Andrés Rodríguez, Daniel Contreras-Reyes, Elmer A. Fernández, Gonzalo Carrasco-Aviño, Alejandro H. Corvalán, Andrew F.G. Quest. Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer. Oncotarget 2018; 9(16): 12853 doi: 10.18632/oncotarget.24402
|
44 |
Mingyu Han, Haifeng Sun, Quanbo Zhou, Jinbo Liu, Junhong Hu, Weitang Yuan, Zhenqiang Sun. Effects of RNA methylation on Tumor angiogenesis and cancer progression. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01879-8
|
45 |
Tomoki Muramatsu, Issei Imoto, Takeshi Matsui, Ken-ichi Kozaki, Shigeo Haruki, Marius Sudol, Yutaka Shimada, Hitoshi Tsuda, Tatsuyuki Kawano, Johji Inazawa. YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 2011; 32(3): 389 doi: 10.1093/carcin/bgq254
|
46 |
Hua Li, Shouhua Wang, Guoying Wang, ZhiGang Zhang, Xiaocai Wu, Tong Zhang, Binsheng Fu, Guihua Chen. Yes-Associated Protein Expression is a Predictive Marker for Recurrence of Hepatocellular Carcinoma after Liver Transplantation. Digestive Surgery 2014; 31(6): 468 doi: 10.1159/000370252
|
47 |
Zenan Yuan, Linsen Ye, Xiao Feng, Tian Zhou, Yi Zhou, Shuguang Zhu, Changchang Jia, Haibo Li, Dongbo Qiu, Kun Li, Wei Liu, Yang Li, Hui Tang, Guoying Wang, Qi Zhang, Yang Yang, Guihua Chen, Hua Li, Olga Pechanova. YAP‐Dependent Induction of CD47‐Enriched Extracellular Vesicles Inhibits Dendritic Cell Activation and Ameliorates Hepatic Ischemia‐Reperfusion Injury. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/6617345
|
48 |
Yujie Sun, Duo Shi, Jiting Sun, Yan Zhang, Wen Liu, Bing Luo. Regulation mechanism of EBV-encoded EBER1 and LMP2A on YAP1 and the impact of YAP1 on the EBV infection status in EBV-associated gastric carcinoma. Virus Research 2024; 343: 199352 doi: 10.1016/j.virusres.2024.199352
|
49 |
Andreas Krieg, Billur Baseras, Monika Tomczak, Pablo Emilio Verde, Nikolas Hendrik Stoecklein, Wolfram Trudo Knoefel. Role of survivin as prognostic and clinicopathological marker in gastric cancer: a meta-analysis. Molecular Biology Reports 2013; 40(9): 5501 doi: 10.1007/s11033-013-2650-z
|
50 |
Wenqi Wang, Jun Huang, Xin Wang, Jingsong Yuan, Xu Li, Lin Feng, Jae-Il Park, Junjie Chen. PTPN14 is required for the density-dependent control of YAP1. Genes & Development 2012; 26(17): 1959 doi: 10.1101/gad.192955.112
|
51 |
Rodrigo Santa Cruz Guindalini, Maria Cecília Mathias Machado, Bernardo Garicochea. Monitoring Survivin Expression in Cancer: Implications for Prognosis and Therapy. Molecular Diagnosis & Therapy 2013; 17(6): 331 doi: 10.1007/s40291-013-0048-1
|
52 |
H Matsumoto, Y Murakami, K Kataoka, H Lin, K M Connor, J W Miller, D Zhou, J Avruch, D G Vavvas. Mammalian STE20-like kinase 2, not kinase 1, mediates photoreceptor cell death during retinal detachment. Cell Death & Disease 2014; 5(5): e1269 doi: 10.1038/cddis.2014.218
|
53 |
Jinglin Zhang, Yuhang Zhou, Patrick M.K. Tang, Alfred S.L. Cheng, Jun Yu, Ka Fai To, Wei Kang. Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis. International Journal of Molecular Sciences 2019; 20(7): 1576 doi: 10.3390/ijms20071576
|